June 2003
Article Features
  Study Questions Short Follow-Up Intervals For 'Probably Benign' Mammographic Findings
Inherited BRCA Mutations Improve Treatment Response and Survival Among Ovarian Cancer Patients
Study of Bacterial Enzyme Reveals One Key to Cancer Cell Survival
Exercise May Contribute to Improved Breast Cancer Survival
Gene Identified in 80% of Breast Cancer Patients
Wide Disparity in Internet Information about Clinical Trials
Technique Brings Immune-Based Therapies Closer To Reality
A Cancer Diagnosis Can Spark a Cascade of Health-Related Lifestyle Changes in Diet, Exercise and Supplement Use
Molecular Analysis of Early Breast Cancer Lesions May Be Key to Choosing Best Treatment
New Study to Search for Molecular Predictors of Breast Cancer
MR Accurate in Detecting Residual Disease Following Lumpectomy
Newly Discovered Mutations Possibly Linked to Breast Cancer
Breast Conservation Surgery with Radiotherapy is an Effective Alternative to Mastectomy to Treat Paget Disease of the Breast
Whole Body PET Proves Accurate in Detecting Breast Cancer Spread
Breast Cancer Deaths Almost Halved After Screening
Oxford Scientists Bolster Sex Hormone Link to Breast Cancer
New Study Identifies Possible Predictor of Tamoxifen Resistance
New Study Finds That Radiation Therapy Targets Cancer Cells in Two Ways
Tumor Cells in Blood May Indicate More Aggressive Breast Cancer


Cancer Patients Have Better Outcomes at Busier Hospitals

Patients who undergo surgery for rectal cancer at high-volume hospitals have better rates of survival and lower rates of permanent colostomy than patients who are operated on at low-volume hospitals, according to a study in the Journal of the National Cancer Institute.

Hospital volume (i.e., the number of operations performed at a hospital) has been associated with outcomes after surgery for cancers of the pancreas, esophagus, prostate, breast, lung, and colon. However, the association between hospital volume and outcomes after rectal cancer surgery has been less clear.

David C. Hodgson, M.D., of the Princess Margaret Hospital and the University of Toronto in Canada, John Z. Ayanian, M.D., of the Harvard Medical School in Boston, and their colleagues compared outcome measures among 7,257 patients who underwent surgery for rectal cancer.

Hodgson and his colleagues found that patients treated at low-volume hospitals (those performing fewer than 7 rectal cancer operations per year) had a higher postoperative mortality rate (4.8% versus 1.6%) and lower 2-year survival rate (76.6% versus 83.7%) than patients treated at high-volume hospitals (those performing more than 20 operations per year).

Read More of the Main Article

 
Visit the Ezine


Visit the BreastCenter

Visit the Quality Corner
Avon Breast Cancer Crusade - AVON the company for women

  This website is supported in part by an unrestricted educational grant provided by Avon